Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial

NCT05162625 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.

NCT NCT05162625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05162625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial
Lead sponsor
University of Campinas, Brazil
Phase
Phase 2
Overall status
Unknown status
Start date
December 10, 2021
Completion date
December 10, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endophthalmitis, moxifloxacin, open globe injury, post-traumatic endophthalmitis